share_log
Benzinga ·  04/25 12:10

Aclarion Shares Are Trading Higher After the Company Announced That Its Nociscan Solution Will Be Used in the Upcoming LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Aclarion宣佈將在即將進行的評估慢性腰痛診斷和治療的LIFEHAB試驗中使用其Nociscan解決方案後,該公司股價走高

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論